19
Views
87
CrossRef citations to date
0
Altmetric
Original Article

Serum Pepsinogen I and Serum Gastrin in the Screening of Severe Atrophic Corpus Gastritis

, , &
Pages 109-116 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Pentti Sipponen & Heidi-Ingrid Maaroos. (2015) Chronic gastritis. Scandinavian Journal of Gastroenterology 50:6, pages 657-667.
Read now
Catharina Lewerin, Stefan Jacobsson, Göran Lindstedt & Herman Nilsson-Ehle. (2008) Serum biomarkers for atrophic gastritis and antibodies against Helicobacter pylori in the elderly: Implications for vitamin B12, folic acid and iron status and response to oral vitamin therapy. Scandinavian Journal of Gastroenterology 43:9, pages 1050-1056.
Read now
Ana Isabel Lopes, Ana Palha, Teresa Lopes, Lurdes Monteiro, Mónica Oleastro & Afonso Fernandes. (2006) Relationship among serum pepsinogens, serum gastrin, gastric mucosal histology and H. pylori virulence factors in a paediatric population. Scandinavian Journal of Gastroenterology 41:5, pages 524-531.
Read now
M. Plebani & Or. Sander Szabo. (1993) Pepsinogens in Health and Disease. Critical Reviews in Clinical Laboratory Sciences 30:3, pages 273-328.
Read now
K. Varis, M. Kekki, M. Härkönen, P. Sipponen & I. M. Samloff. (1991) Serum Pepsinogen I and Serum Gastrin in the Screening of Atrophic Pangastritis with High Risk of Gastric Cancer. Scandinavian Journal of Gastroenterology 26:sup186, pages 117-123.
Read now

Articles from other publishers (82)

Ludovica Dottori, Giulia Pivetta, Bruno Annibale & Edith Lahner. (2023) Update on Serum Biomarkers in Autoimmune Atrophic Gastritis. Clinical Chemistry.
Crossref
Michele Russo, Kryssia Isabel Rodriguez-Castro, Marilisa Franceschi, Antonio Ferronato, Maria Piera Panozzo, Lorenzo Brozzi, Francesco Di Mario, Pellegrino Crafa, Giovanni Brandimarte & Antonio Tursi. (2023) Appropriateness of Proton Pump Inhibitor Prescription Evaluated by Using Serological Markers. International Journal of Molecular Sciences 24:3, pages 2378.
Crossref
Xiaodong Zou, Hongsheng Ouyang, Daxin Pang, Renzhi Han & Xiaochun Tang. (2021) Pathological alterations in the gastrointestinal tract of a porcine model of DMD. Cell & Bioscience 11:1.
Crossref
Yeon-Ji KimChang-Nyol PaikIk Hyun JoDae Bum KimJi Min Lee. (2021) Serum Gastrin Predicts Hydrogen-Producing Small Intestinal Bacterial Overgrowth in Patients With Abdominal Surgery: A Prospective Study. Clinical and Translational Gastroenterology 12:1, pages e00291.
Crossref
Khitam Muhsen, Samba O. Sow, Milagritos D. Tapia, Fadima C. Haidara, Mardi Reymann, Valeria Asato, Wilbur H. Chen, Marcela F. Pasetti & Myron M. Levine. (2020) Pre-existing Helicobacter pylori serum IgG enhances the vibriocidal antibody response to CVD 103-HgR live oral cholera vaccine in Malian adults. Scientific Reports 10:1.
Crossref
Khitam Muhsen, Ronit Sinnreich, Dafna Merom, Hisham Nassar, Dani Cohen & Jeremy D. Kark. (2019) Helicobacter pylori infection, serum pepsinogens as markers of atrophic gastritis, and leukocyte telomere length: a population-based study. Human Genomics 13:1.
Crossref
Khitam Muhsen, Ronit Sinnreich, Dafna Merom, Gany Beer-Davidson, Hisham Nassar, Dani Cohen & Jeremy D Kark. (2019) Prevalence and determinants of serological evidence of atrophic gastritis among Arab and Jewish residents of Jerusalem: a cross-sectional study. BMJ Open 9:1, pages e024689.
Crossref
Oya Yucel. (2018) Interactions between Helicobacter pylori and gastroesophageal reflux disease. Esophagus 16:1, pages 52-62.
Crossref
Khitam Muhsen, Ronit Sinnreich, Gany Beer-Davidson, Hisham Nassar, Daniel Cohen & Jeremy D. Kark. (2018) Sero-prevalence of Helicobacter pylori CagA immunoglobulin G antibody, serum pepsinogens and haemoglobin levels in adults. Scientific Reports 8:1.
Crossref
Hala El-Zimaity, Won-Tak Choi, Gregory Y. Lauwers & Robert Riddell. (2018) The differential diagnosis of Helicobacter pylori negative gastritis. Virchows Archiv 473:5, pages 533-550.
Crossref
Tomomitsu Tahara, Tomoyuki Shibata, Tomohiko Kawamura, Takamitsu Ishizuka, Masaaki Okubo, Mitsuo Nagasaka, Yoshihito Nakagawa, Tomiyasu Arisawa, Naoki Ohmiya & Ichiro Hirata. (2015) Telomere length in non-neoplastic gastric mucosa and its relationship to H. pylori infection, degree of gastritis, and NSAID use. Clinical and Experimental Medicine 16:1, pages 65-71.
Crossref
Ya-kai Huang, Jian-chun Yu, Wei-ming Kang, Zhi-qiang Ma, Xin Ye, Shu-bo Tian & Chao Yan. (2015) Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis. PLOS ONE 10:11, pages e0142080.
Crossref
Arne Kandulski, Marino Venerito & Peter Malfertheiner. 2015. Esophageal cancer and barrett's esophagus. Esophageal cancer and barrett's esophagus 79 86 .
M. Venerito, M. Radünz, K. Reschke, D. Reinhold, K. Frauenschläger, D. Jechorek, F. Di Mario & P. Malfertheiner. (2015) Autoimmune gastritis in autoimmune thyroid disease. Alimentary Pharmacology & Therapeutics 41:7, pages 686-693.
Crossref
Ya. M. Vakhrushev, A. Yu. Gorbunov, D. V. Tronina, E. V. Suchkova, M. V. Lyapina & N. A. Khokhlacheva. (2015) Cholelithiasis as a possible manifestation of systemic digestive diseases. Terapevticheskii arkhiv 87:2, pages 54.
Crossref
Marino Venerito & Peter Malfertheiner. (2015) Preneoplastic Conditions in the Stomach: Always a Point of No Return. Digestive Diseases 33:1, pages 5-10.
Crossref
Kari J. Syrjänen, Penti Sipponen, Matti Härkönen, Ants Peetsalu & Semi Korpela. (2015) Accuracy of the GastroPanel test in the detection of atrophic gastritis. European Journal of Gastroenterology & Hepatology 27:1, pages 102-104.
Crossref
Yangyang Gao, Fei Song & Yajuan Qin. (2014) IDDTL: A Novel Identified Internet Data Transport Layer Mechanism. Journal of Networks 9:1.
Crossref
Hala El‐Zimaity & Robert H. Riddell. 2013. Morson and Dawson's Gastrointestinal Pathology. Morson and Dawson's Gastrointestinal Pathology 110 161 .
C.A. González, F. Megraud, A. Buissonniere, L. Lujan Barroso, A. Agudo, E.J. Duell, M.C. Boutron-Ruault, F. Clavel-Chapelon, D. Palli, V. Krogh, A. Mattiello, R. Tumino, C. Sacerdote, J.R. Quirós, E. Sanchez-Cantalejo, C. Navarro, A. Barricarte, M. Dorronsoro, K.-T. Khaw, N. Wareham, N.E. Allen, K.K. Tsilidis, H. Bas Bueno-de-Mesquita, S.M. Jeurnink, M.E. Numans, P.H.M. Peeters, P. Lagiou, E. Valanou, A. Trichopoulou, R. Kaaks, A. Lukanova-McGregor, M.M. Bergman, H. Boeing, J. Manjer, B. Lindkvist, R. Stenling, G. Hallmans, L.M. Mortensen, K. Overvad, A. Olsen, A. Tjonneland, K. Bakken, V. Dumeaux, E. Lund, M. Jenab, I. Romieu, D. Michaud, T. Mouw, F. Carneiro, C. Fenge & E. Riboli. (2012) Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project. Annals of Oncology 23:5, pages 1320-1324.
Crossref
Tomomitsu Tahara, Tomoyuki Shibata, Masakatsu Nakamura, Joh Yonemura, Masaaki Okubo, Daisuke Yoshioka, Yoshio Kamiya, Tomiyasu Arisawa & Ichiro Hirata. (2011) Presence of Minimal Change Esophagitis Closely Correlates with Pathological Conditions in the Stomach. Digestive Diseases and Sciences 57:4, pages 958-966.
Crossref
Carlos A. González & Antonio Agudo. (2011) Carcinogenesis, prevention and early detection of gastric cancer: Where we are and where we should go. International Journal of Cancer 130:4, pages 745-753.
Crossref
Dominique Noah Noah, Marie Claire Okomo Assoumou, Servais Albert Fiacre Eloumou Bagnaka, Guy Pascal Ngaba, Ivo Ebule Alonge, Lea Paloheimo & Oudou Njoya. (2012) Assessing GastroPanel serum markers as a non-invasive method for the diagnosis of atrophic gastritis and <i>Helicobacter pylori</i> infection. Open Journal of Gastroenterology 02:03, pages 113-118.
Crossref
Bruno Annibale, Edith Lahner & Gianfranco Delle Fave. (2011) Diagnosis and Management of Pernicious Anemia. Current Gastroenterology Reports 13:6, pages 518-524.
Crossref
Marino Venerito, Sabine Kohrs, Thomas Wex, Daniela Adolf, Doerthe Kuester, Daniel Schubert, Ulrich Peitz, Klaus Mönkemüller & Peter Malfertheiner. (2011) Helicobacter pylori infection and fundic gastric atrophy are not associated with esophageal squamous cell carcinoma. European Journal of Gastroenterology & Hepatology 23:10, pages 859-864.
Crossref
N. Alonso, M. L. Granada, B. Soldevila, I. Salinas, C. Joaquin, J. L. Reverter, J. Juncà, E. M. Martínez Cáceres & A. Sanmartí. (2010) Serum autoimmune gastritis markers, pepsinogen I and parietal cell antibodies, in patients with Type 1 diabetes mellitus: A 5-year prospective study. Journal of Endocrinological Investigation 34:5, pages 340-344.
Crossref
Masaaki Okubo, Tomomitsu Tahara, Tomoyuki Shibata, Hiromi Yamashita, Masakatsu Nakamura, Daisuke Yoshioka, Joh Yonemura, Takamitsu Ishizuka, Tomiyasu Arisawa & Ichiro Hirata. (2010) Association Between Common Genetic Variants in Pre‐microRNAs and Gastric Cancer Risk in Japanese Population. Helicobacter 15:6, pages 524-531.
Crossref
Edith Lahner, Marialuisa Spoletini, Raffaella Buzzetti, Vito D. Corleto, Lucy Vannella, Antonio Petrone & Bruno Annibale. (2010) HLA-DRB1*03 and DRB1*04 are associated with atrophic gastritis in an Italian population. Digestive and Liver Disease 42:12, pages 854-859.
Crossref
Lucio Lombardo, Rosalia Leto, Giancarlo Molinaro, Marco Migliardi, Nicoletta Ravarino, Rodolfo Rocca & Bruno Torchio. (2010) Prevalence of atrophic gastritis in dyspeptic patients in Piedmont. A survey using the GastroPanel test. Clinical Chemistry and Laboratory Medicine 48:9.
Crossref
Simone J.P.M. Eussen, Stein Emil Vollset, Steinar Hustad, Øivind Midttun, Klaus Meyer, Åse Fredriksen, Per Magne Ueland, Mazda Jenab, Nadia Slimani, Pietro Ferrari, Antonio Agudo, Núria Sala, Gabriel Capellá, Giuseppe Del Giudice, Domenico Palli, Heiner Boeing, Cornelia Weikert, H. Bas Bueno-de-Mesquita, Frederike L. Büchner, Fátima Carneiro, Franco Berrino, Paolo Vineis, Rosario Tumino, Salvatore Panico, Göran Berglund, Jonas Manjer, Roger Stenling, Göran Hallmans, Carmen Martínez, Larraitz Arrizola, Aurelio Barricarte, Carmen Navarro, Laudina Rodriguez, Sheila Bingham, Jakob Linseisen, Rudolf Kaaks, Kim Overvad, Anne Tjønneland, Petra H.M. Peeters, Mattijs E. Numans, Françoise Clavel-Chapelon, Marie-Christine Boutron-Ruault, Sophie Morois, Antonia Trichopoulou, Eiliv Lund, Mario Plebani, Elio Riboli & Carlos A. González. (2010) Vitamins B2 and B6 and Genetic Polymorphisms Related to One-Carbon Metabolism as Risk Factors for Gastric Adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiology, Biomarkers & Prevention 19:1, pages 28-38.
Crossref
Hala El-Zimaity. (2009) Corpus predominant gastritis: what does it mean?. Current Opinion in Gastroenterology 25:6, pages 566-569.
Crossref
Edith Lahner, Gary L Norman, Carola Severi, Susan Encabo, Zakera Shums, Lucy Vannella, Gianfranco Delle Fave & Bruno Annibale. (2009) Reassessment of Intrinsic Factor and Parietal Cell Autoantibodies in Atrophic Gastritis With Respect to Cobalamin Deficiency. The American Journal of Gastroenterology 104:8, pages 2071-2079.
Crossref
Tomomitsu Tahara, Tomoyuki Shibata, Masakatsu Nakamura, Daisuke Yoshioka, Masaaki Okubo, Tomiyasu Arisawa & Ichiro Hirata. (2009) Gastric mucosal pattern by using magnifying narrow-band imaging endoscopy clearly distinguishes histological and serological severity of chronic gastritis. Gastrointestinal Endoscopy 70:2, pages 246-253.
Crossref
C. J. VAN MARREWIJK, M. G. H. VAN OIJEN, L. I. PALOHEIMO, G. A. J. FRANSEN, S. MUJAKOVIC, J. W. M. MURIS, M. E. NUMANS, N. J. DE WIT, D. E. GROBBEE, J. A. KNOTTNERUS, R. J. F. LAHEIJ & J. B. M. J. JANSEN. (2009) Influence of gastric mucosal status on success of stepwise acid suppressive therapy for dyspepsia. Alimentary Pharmacology & Therapeutics 30:1, pages 82-89.
Crossref
Tomomitsu Tahara, Tomiyasu Arisawa, Tomoyuki Shibata, Masakatsu Nakamura, Daisuke Yoshioka, Masaaki Okubo, Naoko Maruyama, Toshiaki Kamano, Yoshio Kamiya, Hiroshi Fujita, Yoshihito Nakagawa, Mitsuo Nagasaka, Masami Iwata, Kazuya Takahama, Makoto Watanabe, Hiromi Yamashita & Ichiro Hirata. (2009) Increased number of methylated CpG islands correlates with Helicobacter pylori infection, histological and serological severity of chronic gastritis. European Journal of Gastroenterology & Hepatology 21:6, pages 613-619.
Crossref
Edith Lahner & Bruno Annibale. (2009) Pernicious anemia: New insights from a gastroenterological point of view. World Journal of Gastroenterology 15:41, pages 5121.
Crossref
G. Capella, G. Pera, N. Sala, A. Agudo, F. Rico, G. Del Giudicce, M. Plebani, D. Palli, H. Boeing, H B. Bueno-de-Mesquita, F. Carneiro, F. Berrino, P. Vineis, R. Tumino, S. Panico, G. Berglund, H. Siman, O. Nyren, G. Hallmans, C. Martinez, M. Dorronsoro, A. Barricarte, C. Navarro, J. R Quiros, N. Allen, T. Key, S. Bingham, C. Caldas, J. Linseisen, G. Nagel, K. Overvad, A. Tjonneland, H. C Boshuizen, P. H. Peeters, M. E Numans, F. Clavel-Chapelon, A. Trichopoulou, E. Lund, M. Jenab, R. Kaaks, E. Riboli & C. A Gonzalez. (2008) DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study. International Journal of Epidemiology 37:6, pages 1316-1325.
Crossref
Tomomitsu Tahara, Tomiyasu Arisawa, Tomoyuki Shibata, Masakatsu Nakamura, Fangyu Wang, Naoko Maruyama, Yoshio Kamiya, Masahiko Nakamura, Hiroshi Fujita, Mitsuo Nagasaka, Masami Iwata, Kazuya Takahama, Makoto Watanabe, Ichiro Hirata & Hiroshi Nakano. (2007) Influence of Peroxisome Proliferator-activated Receptor (PPAR)γ Plo12Ala Polymorphism as a Shared Risk Marker for Both Gastric Cancer and Impaired Fasting Glucose (IFG) in Japanese. Digestive Diseases and Sciences 53:3, pages 614-621.
Crossref
Edith Lahner, Marco Centanni, Giacoma Agnello, Lucilla Gargano, Lucy Vannella, Carlo Iannoni, Gianfranco Delle Fave & Bruno Annibale. (2008) Occurrence and Risk Factors for Autoimmune Thyroid Disease in Patients with Atrophic Body Gastritis. The American Journal of Medicine 121:2, pages 136-141.
Crossref
Ayako Yanai, Shin Maeda, Yoko Hikiba, Wataru Shibata, Tomoya Ohmae, Yoshihiro Hirata, Keiji Ogura, Haruhiko Yoshida & Masao Omata. (2007) Clinical relevance of Helicobacter pylori sabA genotype in Japanese clinical isolates. Journal of Gastroenterology and Hepatology 22:12, pages 2228-2232.
Crossref
Serenella Checchi, Annalisa Montanaro, Letizia Pasqui, Cristina Ciuoli, Gabriele Cevenini, Fausta Sestini, Carla Fioravanti & Furio Pacini. (2007) Serum Ghrelin as a Marker of Atrophic Body Gastritis in Patients with Parietal Cell Antibodies. The Journal of Clinical Endocrinology & Metabolism 92:11, pages 4346-4351.
Crossref
Martijn G. H. van Oijen, Pentti Sipponen, Robert J. F. Laheij, Freek W. A. Verheugt & Jan B. M. J. Jansen. (2007) Gastric Status and Vitamin B12 Levels in Cardiovascular Patients. Digestive Diseases and Sciences 52:9, pages 2186-2189.
Crossref
Mario Plebani & Daniela Basso. (2007) Non-invasive assessment of chronic liver and gastric diseases. Clinica Chimica Acta 381:1, pages 39-49.
Crossref
Jordi Juncà, Paloma López de Soria, Maria Luisa Granada, Alonso Flores & Eugenia Márquez. (2006) Detection of early abnormalities in gastric function in first-degree relatives of patients with pernicious anemia. European Journal of Haematology 77:6, pages 518-522.
Crossref
Kazumasa Miki. (2006) Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer 9:4, pages 245-253.
Crossref
T. Shimatani, M. Moriwaki, J. Xu, S. Tazuma & M. Inoue. (2006) Acid-suppressive effects of rabeprazole: Comparing 10mg and 20mg twice daily in Japanese Helicobacter pylori-negative and -positive CYP2C19 extensive metabolisers. Digestive and Liver Disease 38:11, pages 802-808.
Crossref
S.N. Wickramasinghe. (2006) Diagnosis of megaloblastic anaemias. Blood Reviews 20:6, pages 299-318.
Crossref
Francesco Di Mario, Lucas Giovanni Cavallaro, Ali Mahamat Moussa, Pietro Caruana, Roberta Merli, Andrea Maini, Simone Bertolini, Nadia Dal Bó, Massimo Rugge, Giulia Martina Cavestro, Giovanni Aragona, Mario Plebani, Angelo Franzé & Giorgio Nervi. (2006) Usefulness of Serum Pepsinogens in Helicobacter pylori Chronic Gastritis: Relationship With Inflammation, Activity, and Density of the Bacterium. Digestive Diseases and Sciences 51:10, pages 1791-1795.
Crossref
Andr?? Korstanje, Gijsbert den Hartog, Izak Biemond, Freek W.C. Roelandse, John H.M. Souverijn & Cornelis B.H.W. Lamers. (2006) Role of Helicobacter pylori and autoimmunity in serological atrophic corpus gastritis in a Dutch primary care community. European Journal of Gastroenterology & Hepatology 18:8, pages 911-916.
Crossref
Paul Knekt, Lyly Teppo, Arpo Aromaa, Harri Rissanen & Timo U. Kosunen. (2006) Helicobacter pylori IgA and IgG antibodies, serum pepsinogen I and the risk of gastric cancer: Changes in the risk with extended follow-up period. International Journal of Cancer 119:3, pages 702-705.
Crossref
David Y. Graham, Zhannat Z. Nurgalieva, Hala M.T. El-Zimaity, Antone R. Opekun, Armando Campos, Leoncio Guerrero, Alfredo Chavez & Victor Cardenas. (2006) Noninvasive Versus Histologic Detection of Gastric Atrophy in a Hispanic Population in North America. Clinical Gastroenterology and Hepatology 4:3, pages 306-314.
Crossref
Antonio Rollan. (2006) Non-invasive diagnosis of gastric mucosal atrophy in an asymptomatic population with high prevalence of gastric cancer. World Journal of Gastroenterology 12:44, pages 7172.
Crossref
Georges Dimitrov. (2006) Does gastric atrophy exist in children. World Journal of Gastroenterology 12:39, pages 6274.
Crossref
Yasuyuki Goto, Takafumi Ando, Kazuhito Yamamoto, Akiko Tamakoshi, Emad El‐Omar, Hidemi Goto & Nobuyuki Hamajima. (2005) Association between serum pepsinogens and polymorphismof PTPN11 encoding SHP‐2 among Helicobacter pylori seropositive Japanese . International Journal of Cancer 118:1, pages 203-208.
Crossref
B. Germaná, F. Di Mario, L.G. Cavallaro, A.M. Moussa, P. Lecis, S. Liatoupolou, G. Comparato, C. Carloni, G. Bertiato, M. Battiestel, N. Papa, G. Aragona, G.M. Cavestro, V. Iori, R. Merli, S. Bertolini, P. Caruana & A. Franzé. (2005) Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacter pylori antibodies in the management of dyspeptic patients in primary care. Digestive and Liver Disease 37:7, pages 501-508.
Crossref
Edith Lahner. (2005) Possible contribution of advanced statistical methods (artificial neural networks and linear discriminant analysis) in recognition of patients with suspected atrophic body gastritis. World Journal of Gastroenterology 11:37, pages 5867.
Crossref
T. Ohkusa, H. Miwa, T. Nomura, D. Asaoka, A. Kurosawa, N. Sakamoto, S. Abe, M. Hojo, T. Terai, T. Ogihara & N. Sato. (2004) Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori : comparison with H. pylori-negative patients . Alimentary Pharmacology & Therapeutics 20, pages 25-32.
Crossref
Victor D. Pasechnikov. (2004) Possibility of non-invasive diagnosis of gastric mucosal precancerous changes. World Journal of Gastroenterology 10:21, pages 3146.
Crossref
H Väänänen, M Vauhkonen, T Helske, I Kääriäinen, M Rasmussen, H Tunturi-Hihnala, J Koskenpato, M Sotka, M Turunen, R Sandström, M Ristikankare, A Jussila & P Sipponen. (2003) Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I. European Journal of Gastroenterology & Hepatology 15:8, pages 885-891.
Crossref
N Broutet, M Plebani, C Sakarovitch, P Sipponen & F Mégraud. (2003) Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. British Journal of Cancer 88:8, pages 1239-1247.
Crossref
Lisa M. Rogers, Erick Boy, Joshua W. Miller, Ralph Green, Monica Rodriguez, Francisco Chew & Lindsay H. Allen. (2003) Predictors of Cobalamin Deficiency in Guatemalan School Children: Diet, Helicobacter pylori, or Bacterial Overgrowth?. Journal of Pediatric Gastroenterology and Nutrition 36:1, pages 27-36.
Crossref
C.-J. Tsai & J. Parsonnet. 2003. Helicobactor pylori. Helicobactor pylori 149 160 .
P. Sipponen, O. Suovaniemi & M. Härkönen. 2003. Helicobactor pylori. Helicobactor pylori 127 132 .
M. Ito, K. Haruma, T. Kamada, M. Mihara, S. Kim, Y. Kitadai, M. Sumii, S. Tanaka, M. Yoshihara & K. Chayama. (2002) Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5‐year prospective study of patients with atrophic gastritis . Alimentary Pharmacology & Therapeutics 16:8, pages 1449-1456.
Crossref
Takahisa Furuta, Emad M. El–Omar, Fang Xiao, Naohito Shirai, Misako Takashima & Haruhiko Sugimurra. (2002) Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 123:1, pages 92-105.
Crossref
Keith Bodger, Judy I. Wyatt & Richard V. Heatley. (2001) Variation in Serum Pepsinogens With Severity and Topography of Helicobacter pylori ‐Associated Chronic Gastritis in Dyspeptic Patients Referred for Endoscopy . Helicobacter 6:3, pages 216-224.
Crossref
Ralph Carmel, Imran Aurangzeb & Dajun Qian. (2001) Associations of food-cobalamin malabsorption with ethnic origin, age, Helicobacter pylori infection, and serum markers of gastritis. The American Journal of Gastroenterology 96:1, pages 63-70.
Crossref
M. Sagar, L. Bertilsson, M. Stridsberg, A. Kjellin, S. Mårdh & R. Seensalu. (2001) Omeprazole and CYP2C19 polymorphism: effects of long‐term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disorders. Alimentary Pharmacology & Therapeutics 14:11, pages 1495-1502.
Crossref
Jordi Juncà, Alonso Flores, Maria Luisa Granada, Orlando Jiménez & Juan M. Sancho. (2008) The relationship between idiopathic thrombocytopenic purpura and pernicious anaemia. British Journal of Haematology 111:2, pages 513-516.
Crossref
Jordi Junca, Alonso Flores, Maria Luisa Granada, Orlando Jimenez & Juan M. Sancho. (2000) The relationship between idiopathic thrombocytopenic purpura and pernicious anaemia. British Journal of Haematology 111:2, pages 513-516.
Crossref
G. Richard Locke, Nicholas J. Talley, Daniel K. Nelson, Ken Haruma, Amy L. Weaver, Alan R. Zinsmeister & L. Joseph Melton. (2000) Helicobacter pylori and dyspepsia: a population-based study of the organism and host. The American Journal of Gastroenterology 95:8, pages 1906-1913.
Crossref
M Marignani, Delle G Fave, S Mecarocci, C Bordi, S Angeletti, G D'Ambra, M R Aprile, V D Corleto, B Monarca & B Annibale. (1999) High Prevalence of Atrophic Body Gastritis in Patients With Unexplained Microcytic and Macrocytic Anemia. American Journal of Gastroenterology 94:3, pages 766-772.
Crossref
A. Lindgren, A. Lindgren, G. Lindstedt & A. F. Kilander. (2002) Advantages of serum pepsinogen A combined with gastrin or pepsinogen C as first‐line analytes in the evaluation of suspected cobalamin deficiency: a study in patients previously not subjected to gastrointestinal surgery. Journal of Internal Medicine 244:4, pages 341-349.
Crossref
Antoinette M. KuzminskiEric J. Del GiaccoRobert H. AllenSally P. StablerJohn Lindenbaum. (1998) Effective Treatment of Cobalamin Deficiency With Oral Cobalamin. Blood 92:4, pages 1191-1198.
Crossref
Antoinette M. KuzminskiEric J. Del GiaccoRobert H. AllenSally P. StablerJohn Lindenbaum. (1998) Effective Treatment of Cobalamin Deficiency With Oral Cobalamin. Blood 92:4, pages 1191-1198.
Crossref
Mario Plebani, Daniela Basso, Filippo Navaglia & Francesco DiMario. (2008) Helicobacter pylori Genotypes Inf luence Serum Pepsinogen C Levels . Helicobacter 2:4, pages 172-175.
Crossref
Toshifumi Ohkusa, Ichizen Takashimizu, Kazuhiko Fujiki, Akihiro Araki, Kimio Honda, Kengo Shimoi, Toshiaki Sakurazawa, Takao Horiuchi, Shinji Suzuki, Kouichiro Ariake & Kenichi Ishii. (1997) Changes in Serum Pepsinogen, Gastrin, and Immunoglobulin G Antibody Titers in Helicobacter pylori-Positive Gastric Ulcer after Eradication of Infection. Journal of Clinical Gastroenterology 25:1, pages 317-322.
Crossref
Jaw-Town Lin, Wen-Chung Lee, Ming-Shiang Wu, Jin-Town Wang, Teh-Hong Wang & Chien-Jen Chen. (1995) Diagnosis of gastric adenocarcinoma using a scoring system: Combined assay of serological markers ofHelicobacter pylori infection, pepsinogen I and gastrin. Journal of Gastroenterology 30:2, pages 156-161.
Crossref
J. Kreuning, J. Lindeman, I. Biemond & C. B. H. W. Lamers. (1995) Serological parameters in assessment of degree of gastritis in healthy volunteers. Digestive Diseases and Sciences 40:3, pages 609-614.
Crossref
Haruhiko Fukuda, Daizo Saito, Shuya Hayashi, Hiroyuki Hisai, Hiroyuki Ono, Shigeaki Yoshida, Yanao Oguro, Takeshi Noda, Toshiya Sato, Masaru Katoh, Masaaki Terada & Takashi Sugimura. (2005) Helicobacter pylori Infection, Serum Pepsinogen Level and Gastric Cancer: A Case‐Control Study in Japan . Japanese Journal of Cancer Research 86:1, pages 64-71.
Crossref
E. De Koster, M. Buset, E. Fernandes & M. Deltenre. (1995) Helicobacter pylori et lésions précancéreuses de l’estomacHelicobacter pylori and cancer prone lesions of the stomach. Acta Endoscopica 25:1, pages 33-44.
Crossref
Penelope M. Webb, Klaus J. Hengels, Henrik Møller, Diane G. Newell, Domenico Palli, James B. Elder, Michael P. Coleman & Guy De Backer. (1994) The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates. Gastroenterology 107:5, pages 1335-1344.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.